Literature DB >> 3027896

U3 sequences from HTLV-I and -II LTRs confer pX protein response to a murine leukemia virus LTR.

H Kitado, I S Chen, N P Shah, A J Cann, K Shimotohno, H Fan.   

Abstract

Human T-cell leukemia virus (HTLV) types I and II are unusual among replication-competent retroviruses in that they contain a fourth gene (chi) necessary for replication. The chi gene product, p chi, transcriptionally transactivates the viral long repeat (LTR), and is thus a positive regulator. To investigate p chi transactivation, sequences from the U3 regions of the LTRs of HTLV-I and -II were inserted into the Moloney murine leukemia virus (M-MuLV) LTR by recombinant DNA techniques. Transient expression assays of the chimeric LTRs indicated that the HTLV sequences conferred to the M-MuLV LTR responsiveness to HTLV p chi protein. M-MuLV enhancers were not required for function of the chimeric LTRs. Infectious recombinant M-MuLVs containing chimeric LTRs were also generated. These viruses showed higher infectivity when assayed in mouse cells expressing HTLV-II p chi protein compared to normal mouse cells. Thus the HTLV sequences were able to confer p chi responsiveness to infectious M-MuLV. The generation of a virus dependent on a transactivating protein for its replication has implications for the evolution of the human T-cell leukemia viruses.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3027896     DOI: 10.1126/science.3027896

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  17 in total

1.  Studies of heterologous promoter trans-activation by the HTLV-II tax protein.

Authors:  J L Williams; A J Cann; T Leff; P Sassone-Corsi; I S Chen
Journal:  Nucleic Acids Res       Date:  1989-07-25       Impact factor: 16.971

Review 2.  The human T-cell leukemia virus Rex protein.

Authors:  Ihab Younis; Patrick L Green
Journal:  Front Biosci       Date:  2005-01-01

3.  Protein kinase A-dependent binding of a nuclear factor to the 21-base-pair repeat of the human T-cell leukemia virus type I long terminal repeat.

Authors:  H T Poteat; F Y Chen; P Kadison; J G Sodroski; W A Haseltine
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

4.  Chemical synthesis of biologically active tat trans-activating protein of human immunodeficiency virus type 1.

Authors:  R Chun; C G Glabe; H Fan
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

Review 5.  The origin and evolution of human T-cell lymphotropic virus types I and II.

Authors:  Y Suzuki; T Gojobori
Journal:  Virus Genes       Date:  1998       Impact factor: 2.332

6.  In vitro mutagenesis of the human T-cell leukemia virus types I and II tax genes.

Authors:  A J Cann; J D Rosenblatt; W Wachsman; I S Chen
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

7.  Chromatin structure of recombinant Moloney murine leukemia virus proviral DNAs that contain tax-responsive sequences from human T-cell lymphotropic virus type II in the presence and absence of tax.

Authors:  H Kitado; H Fan
Journal:  J Virol       Date:  1989-07       Impact factor: 5.103

8.  A Moloney murine leukemia virus driven by the Jaagsiekte sheep retrovirus enhancers shows enhanced specificity for infectivity in lung epithelial cells.

Authors:  Kathleen McGee-Estrada; Massimo Palmarini; Claus Hallwirth; Hung Fan
Journal:  Virus Genes       Date:  2005-12       Impact factor: 2.332

9.  Selective infection of human T-lymphotropic virus type 1 (HTLV-1)-infected cells by chimeric human immunodeficiency viruses containing HTLV-1 tax response elements in the long terminal repeat.

Authors:  H C Lin; M Bodkin; R B Lal; A B Rabson
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

10.  Uncovering the microbiota in renal cell carcinoma tissue using 16S rRNA gene sequencing.

Authors:  Junpeng Wang; Xin Li; Xiaoqiang Wu; Zhiwei Wang; Chan Zhang; Guanghui Cao; Kangdong Liu; Tianzhong Yan
Journal:  J Cancer Res Clin Oncol       Date:  2020-11-21       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.